Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06670677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk

Study acronym: FORESEE2024
StatusRecruiting
PhaseNot specified
SponsorAktiia SA
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 2 · Primary and study completion dates: Mar 31, 2035 to May 31, 2035 · Start date changed from estimate of Mar 31, 2025 to May 12, 2025v4 Show 3 more changesShow less
    • Study sites: 0 to 2
    • Primary and study completion dates: Mar 31, 2035 to May 31, 2035
    • Start date changed from estimate of Mar 31, 2025 to May 12, 2025
  2. Start date: Nov 30, 2024 to Mar 31, 2025 Primary and study completion dates: Dec 31, 2035 to Mar 31, 2035v3 Show 1 more changeShow less
    • Primary and study completion dates: Dec 31, 2035 to Mar 31, 2035
  3. Enrollment target: 4000000 to 15000 Study description revisedv2 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aktiia SA
9 trials monitored
See all monitored trials
Hypertension
1,795 trials monitored
See 85 trials at risk
Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.
Trial Details
NCT Number NCT06670677
Lead Sponsor Aktiia SA
Conditions Hypertension, Cardiovascular Risk, Blood Pressure Check (Hypertension Screening)
Enrollment 15,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov